Carole Ho
Chief Tech/Sci/R&D Officer bei DENALI THERAPEUTICS INC.
Vermögen: 7 Mio $ am 31.03.2024
Profil
Dr. Carole Ho, MD, ist ein unabhängiges Vorstandsmitglied bei NGM Biopharmaceuticals, Inc. und ein unabhängiges Vorstandsmitglied bei Beam Therapeutics, Inc. sowie Chief Medical Officer & Head-Development bei Denali Therapeutics, Inc. Sie ist Mitglied des Board of Directors von NGM Biopharmaceuticals, Inc. und Beam Therapeutics, Inc. Dr. Ho war zuvor als VP-Non Oncology Early Clinical Development bei Genentech, Inc. und als Medical Director bei Johnson & Johnson tätig. Sie erhielt ihren Bachelor-Abschluss am Harvard College und ihren Doktortitel am Weill Cornell Medical College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
DENALI THERAPEUTICS INC.
0,25% | 14.02.2024 | 351 824 ( 0,25% ) | 7 Mio $ | 31.03.2024 |
BEAM THERAPEUTICS, INC.
-.--% | 06.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Carole Ho
Unternehmen | Position | Beginn |
---|---|---|
DENALI THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01.06.2015 |
BEAM THERAPEUTICS INC. | Director/Board Member | 15.11.2018 |
Ehemalige bekannte Positionen von Carole Ho
Unternehmen | Position | Ende |
---|---|---|
NGM BIOPHARMACEUTICALS, INC. | Director/Board Member | 05.04.2024 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.06.2015 |
JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | 01.10.2007 |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Ausbildung von Carole Ho
Cornell University | Doctorate Degree |
Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
JOHNSON & JOHNSON | Health Technology |
NGM BIOPHARMACEUTICALS, INC. | Health Technology |
DENALI THERAPEUTICS INC. | Health Technology |
BEAM THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |